PHARMACYTE BIOTECH INC COM NEW

PHARMACYTE BIOTECH INC COM NEW is a security (CUSIP 71715X203) tracked across SEC portfolio filings. 31 institutional managers reported $717K on Form 13F as of 2026-06-30; 1 registered fund positions totaling $34K via N-PORT as of 2026-03-31.

Summary

Top institutional holders (Form 13F)

Showing 15 of 31 managers by value.

ManagerLocationValueShares
CITADEL ADVISORS LLCMIAMI, FL$346K359,547
GEODE CAPITAL MANAGEMENT, LLCBOSTON, MA$130K195,660
VANGUARD GROUP INCValley Forge, PA$54K74,919
RENAISSANCE TECHNOLOGIES LLCNEW YORK, NY$38K56,500
XTX Topco LtdLONDON, X0$35K52,362
NORTHERN TRUST CORPCHICAGO, IL$24K35,601
Schonfeld Strategic Advisors LLCNEW YORK, NY$18K27,009
EQUITEC PROPRIETARY MARKETS, LLCCHICAGO, IL$17K22,227
COMMONWEALTH EQUITY SERVICES, LLCWALTHAM, MA$16K20,255
SIMPLEX TRADING, LLCCHICAGO, IL$13K19,940
TWO SIGMA SECURITIES, LLCNew York, NY$11K16,360
JANE STREET GROUP, LLCNEW YORK, NY$8K11,530
Tower Research Capital LLC (TRC)NEW YORK, NY$3K4,889
UBS Group AGZurich, V8$3K4,519
GROUP ONE TRADING, L.P.CHICAGO, IL$1K1,785

Top fund holders (N-PORT)

FundRegistrantValue% of fund
VANGUARD EXTENDED MARKET INDEX FUNDVANGUARD INDEX FUNDS$34K0.00%

More